Set filters using the options below and click apply. Then scroll down to the bottom of the page and copy the URL from the RSS feed icon. This path can be used to import (or display) content based on the filters set on this page.
To select multiple items in a select box press ctrl while clicking on the items. Similarly an item may be deselected by pressing ctrl and clicking on the item. (In both cases mac users should press cmd rather than ctrl.)
The RSS feed will contain the 10 most recent News articles matching the selected options
Plan will accelerate a new approach to coronavirus vaccines research and development, to protect against COVID-19 variants and future pandemic threats from new coronaviruses
A new study finds treeshrews increase in size in warmer settings, contrary to established norms.
Sniffing or licking other dogs’ genitalia – the common site of Canine Transmissible Venereal Tumour – can spread this unusual cancer to the nose and mouth.
A new study has found that a highly antibiotic-resistant strain of the superbug MRSA – methicillin resistant Staphylococcus aureus – has emerged in livestock in the last 50 years, probably due to widespread antibiotic use in pig farming.
Asking public engagement professionals for advice, and involving numerous people, Chioma is engaging Nigerian famers in the global fight against antimicrobial resistance.
The lifting of veterinary regulations to allow animals to be moved to safety during Ukraine's humanitarian crisis is unprecedented. Dorien Braam argues for this approach to be replicated in other refugee contexts.
Long-term use of implantable electronic medical devices – such as pacemakers and cochlear implants – is hampered by the body’s reaction to foreign bodies. Now, in a study in mice, a team led by scientists at the University of Cambridge has shown that this reaction can be dramatically reduced by incorporating an anti-inflammatory drug into the silicone coating around the implant.
Prime Minister Boris Johnson announced that DIOSynVax, a biotech spinout of the University of Cambridge, will receive $42 million (about £32 million) to develop a vaccine candidate that could provide protection against both existing and future variants of SARS-CoV-2 – the virus that causes COVID-19 – as well as other major coronaviruses, including those that cause SARS and MERS.
Scientists have found evidence that a type of the antibiotic-resistant superbug MRSA arose in nature long before the use of antibiotics in humans and livestock, which has traditionally been blamed for its emergence.
Safety trials are underway for a vaccine developed by Cambridge researchers that could be used as a booster targeting COVID-19 virus variants and relatives that threaten future coronavirus pandemics.
© 2025 University of Cambridge